Known as Savaysa in North America, the novel oral anticoagulant (NOAC), which can be given once daily, was approved for essentially the same

There are certainly lots of studies related to AF with many still incomplete.

medscape.com/viewarticle/84...

New research has shed light on a mechanism other than multiple infarcts that may contribute to the association between between atrial fibrillation (AF) and decreased brain function[1].

oldestnewest

You may also like...